A four-month randomized, double-blind evaluation of the efficacy of botulinum toxin type a for the treatment of glabellar lines in women with skin types v and VI

Dermatologic Surgery

Volumn 35, Issue 3, 2009, Pages 429-436

  Grimes, Pearl E ^a,b,d   Shabazz, Dwana ^c  

^a Vitiligo and Pigmentation Institute of Southern California   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Dermatology Associates of Northern Virginia   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ABNORMAL SENSATION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FACE MUSCLE; FEMALE; HEADACHE; HUMAN; PATIENT ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN TINGLING; WRINKLE;

EID: 62449242247     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2009.01063.x     Document Type: Article

References (21)

1. American Society of Aesthetic Plastic Surgeons. 2004 Quick Facts on Cosmetic and Reconstructive Plastic Surgery. Available at. Accessed August 1, 2005.
2. Carruthers JA, Lowe NJ, Menter MA, Gibson J. A multicenter, double-blind, randomized, placebo-controlled sudy of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002 46 : 840 9.
3. Carruthers JD, Lowe NJ, Menter MA, Gibson J. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast Reconstr Surg 2003 112 : 1089 98.
4. Allergan Inc. Botox Cosmetic (package insert). Irvine, CA : Allergan Inc 2002.
5. Taylor SC. Skin of color: biology, structure, function, and implications for dermatologic disease. J Am Acad Dermatol 2002 46 (2 Suppl Understanding) : S41 62.
6. Richards GM, Oresajo CO, Halder RM. Structure and function of ethnic skin and hair. Dermatol Clin 2003 21 : 595 600.
7. Grimes PE Sherrod Q. Structural and physiologic differences in the skin of darker racial ethnic groups. In : Grimes PE, editor. Aesthetics and Cosmetic Surgery for Darker Skin Types. Philadelphia : Lippincott Williams & Williams 2008. p. 15 26.
8. Lew H, Yun YS, Lee SY, Kim SJ. Effect of botulinum toxin A on facial wrinkle lines in Koreans. Ophthalmologica 2002 216 : 50 4.
9. Kaidbey KH, Agin PP, Sayre RM, Kligman AM. Photoprotection by melanin - a comparison of black and Caucasian skin. J Am Acad Dermatol 1979 1 : 249 60.
10. Grimes PE. Skin of color: diseases and cosmetic issues of major concern. Cosmet Dermatol 2003 16 : 1 4.
11. Harris MO. The aging face in patients of color: minimally invasive surgical facial rejuvenation - a targeted approach. Dermatol Ther 2004 17 : 206 11.
12. Jackson BA. Cosmetic considerations and nonlaser cosmetic procedures in ethnic skin. Dermatol Clin 2003 21 : 703 12.
13. Hsu TS, Dover JS, Arndt KA. Effect of volume and concentration on the diffusion of botulinum exotoxin A. Arch Dermatol 2004 140 : 1351 4.
14. Schulte-Mattler WJ, Martinez-Castrillo JC. Botulinum toxin therapy of migraine and tension-type headache; comparing different botulinum toxin preparations. Eur J Neurol 2006 13 (Suppl 1) : 51 4.
15. Jain S. A new multiple site marking grid for botulinum toxin application in the treatment of axillary hyperhidrosis. Br J Dermatol 2006 154 : 385 6.
16. Bhidayarsiri R, Truong DD. Expanding use of botulinum toxin. J Neurol Sci 2005 15 : 1 9.
17. Carruthers A, Carruthers J, Said S. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females. Dermatol Surg 2005 31 : 414 22.
18. Lowe NJ, Asher B, Heckman M, et al. Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet. Dermatol Surg 2005 31 : 257 62.
19. Carruthers A, Carruthers J, Said S. Double-blind, randomized, parallel group, dose-ranging study of botulinum toxin type A (BOTOX, Allergan Inc.) in the treatment of glabellar lines. Poster presented at: European Academy of Dermatology and Venerology, October 10, 2001, Munich, Germany.
20. Hankins CL, Strimling R, Rogers GS. Botulinum A toxin for glabellar wrinkles dose and response. Dermatol Surg 1998 24 : 1181 3.
21. Ascher B, Zakine B, Kestemont P, Baspeyras M. A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines. J Am Acad Dermatol 2004 51 : 223 33.